Pete IMO the B-UC P2 trial is more important than the P3 OM trial. Obviously there is little interest in OM since we don't have a deal after hiring LW in January but a Pill for UC that releases in the Colon would be HUGE after a successful P2 trial. BP would be pounding down the door. Hopefully we are still on target for a summer trial.
(2)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links